Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia

J Geriatr Oncol. 2019 May;10(3):510-513. doi: 10.1016/j.jgo.2018.09.002. Epub 2018 Sep 27.

¹ Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL, USA.
² Section of Hematology Oncology, Boston University School of Medicine, Boston, MA, USA.
³ Division of Geriatric and Palliative Medicine, UTHealth McGovern Medical School, Houston, TX, USA.
⁴ Division of Hematology Oncology, University of Illinois at Chicago, Chicago, IL, USA.
⁵ Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, USA.
⁶ Department of Public Health Sciences, The University of Chicago, Chicago, IL, USA.
⁷ Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL, USA; Epidemiology Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: gcalip@uic.edu.

No abstract available

Keywords: Chemoimmunotherapy; Dementia; Diffuse large B-cell lymphoma; Mild cognitive impairment.

Publication types